Exane Derivatives Quest Diagnostics Inc Transaction History
Exane Derivatives
- $157 Million
- Q2 2022
A detailed history of Exane Derivatives transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Exane Derivatives holds 7,435 shares of DGX stock, worth $1.02 Million. This represents 0.63% of its overall portfolio holdings.
Number of Shares
7,435
Previous 6,799
9.35%
Holding current value
$1.02 Million
Previous $930,000
6.24%
% of portfolio
0.63%
Previous 0.29%
Shares
10 transactions
Others Institutions Holding DGX
# of Institutions
923Shares Held
95MCall Options Held
379KPut Options Held
354K-
Vanguard Group Inc Valley Forge, PA14MShares$1.92 Billion0.04% of portfolio
-
Black Rock Inc. New York, NY10.1MShares$1.38 Billion0.03% of portfolio
-
State Street Corp Boston, MA5.26MShares$722 Million0.03% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.85MShares$528 Million0.07% of portfolio
-
Victory Capital Management Inc3.46MShares$475 Million0.48% of portfolio
About QUEST DIAGNOSTICS INC
- Ticker DGX
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 113,887,000
- Market Cap $15.6B
- Description
- Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...